Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Denali Therapeutics (DNLI) Interest & Investment Income (2023 - 2024)

Historic Interest & Investment Income for Denali Therapeutics (DNLI) over the last 2 years, with Q4 2024 value amounting to $15.2 million.

  • Denali Therapeutics' Interest & Investment Income rose 1547.72% to $15.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $64.6 million, marking a year-over-year increase of 2549.46%. This contributed to the annual value of $64.6 million for FY2024, which is 2549.46% up from last year.
  • Per Denali Therapeutics' latest filing, its Interest & Investment Income stood at $15.2 million for Q4 2024, which was up 1547.72% from $16.0 million recorded in Q3 2024.
  • In the past 5 years, Denali Therapeutics' Interest & Investment Income registered a high of $17.6 million during Q2 2024, and its lowest value of $11.0 million during Q1 2023.